Literature DB >> 7564673

Hypokalaemia related to acute chloroquine ingestion.

J L Clemessy1, C Favier, S W Borron, P E Hantson, E Vicaut, F J Baud.   

Abstract

Large doses of chloroquine can cause poisoning. Our aim was to determine the possible relation between the plasma potassium concentration on admission with the severity of acute chloroquine poisoning and to assess the mechanism of chloroquine-induced hypokalaemia. We conducted a retrospective study of 191 consecutive cases. The main data included the occurrence of vomiting before admission, plasma, and urinary potassium concentration at admission, whole blood chloroquine concentration on admission, haemodynamic parameters and ECG, administration of catecholamines and outcome. Mean blood chloroquine level was 20.1 mumol/L (SD 14.3) (therapeutic level < or = 6 mumol/L). Mean plasma potassium concentration was 3.0 mmol/L (0.8) and was lower in the subjects who died than in those who survived (p = 0.0003). Plasma potassium varied directly with the systolic blood pressure and inversely with the QRS and QT. Plasma potassium varied inversely with the blood chloroquine (p = 0.0001; tau = -0.42). Acute chloroquine intoxication is responsible for a hypokalaemia which correlates with the gravity of the intoxication and may be due to a transport-dependent mechanism. Plasma potassium concentrations should be carefully observed, particularly among patients who also receive catecholamine infusions. We should keep in mind, however, that overzealous repletion invokes the risk of subsequent hyperkalaemia and thus should be avoided.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564673     DOI: 10.1016/s0140-6736(95)92711-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

Review 1.  Drugs that cause Torsades de pointes and increase the risk of sudden cardiac death.

Authors:  Deborah L Wolbrette
Journal:  Curr Cardiol Rep       Date:  2004-09       Impact factor: 2.931

Review 2.  Extracellular potassium homeostasis: insights from hypokalemic periodic paralysis.

Authors:  Chih-Jen Cheng; Elizabeth Kuo; Chou-Long Huang
Journal:  Semin Nephrol       Date:  2013-05       Impact factor: 5.299

3.  Delayed therapeutic hypothermia following cardiac arrest secondary to chloroquine toxicity.

Authors:  George Mark Haslam; Matt C Thomas; Stephen R Laver
Journal:  BMJ Case Rep       Date:  2009-03-06

Review 4.  Pathophysiology and management of hypokalemia: a clinical perspective.

Authors:  Robert J Unwin; Friedrich C Luft; David G Shirley
Journal:  Nat Rev Nephrol       Date:  2011-02       Impact factor: 28.314

5.  Concentration-dependent mortality of chloroquine in overdose.

Authors:  James A Watson; Joel Tarning; Richard M Hoglund; Frederic J Baud; Bruno Megarbane; Jean-Luc Clemessy; Nicholas J White
Journal:  Elife       Date:  2020-07-08       Impact factor: 8.140

6.  Secondary hypokalaemic paralysis.

Authors:  Ankush Gupta; Vibhu Narain Khanna; Imran Rizvi; Anirban Gupta
Journal:  BMJ Case Rep       Date:  2012-09-30

7.  Hydroxychloroquine Overdose: What Are the Exact Roles of Diazepam and Potassium Infusion?

Authors:  Bruno Mégarbane; Azzurra Schicchi
Journal:  J Med Toxicol       Date:  2020-09-14

8.  Phase I randomized dose-ascending placebo-controlled trials of ferroquine--a candidate anti-malarial drug--in adults with asymptomatic Plasmodium falciparum infection.

Authors:  Ghyslain Mombo-Ngoma; Christian Supan; Matthias P Dal-Bianco; Michel A Missinou; Pierre-Blaise Matsiegui; Carmen L Ospina Salazar; Saadou Issifou; Daniel Ter-Minassian; Michael Ramharter; Maryvonne Kombila; Peter G Kremsner; Bertrand Lell
Journal:  Malar J       Date:  2011-03-01       Impact factor: 2.979

9.  Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers.

Authors:  Fawaz Mzayek; Haiyan Deng; Frances J Mather; Elizabeth C Wasilevich; Huayin Liu; Christiane M Hadi; David H Chansolme; Holly A Murphy; Bekir H Melek; Alan N Tenaglia; David M Mushatt; Albert W Dreisbach; Juan J L Lertora; Donald J Krogstad
Journal:  PLoS Clin Trials       Date:  2007-01-05

10.  Novel Therapies for Myocardial Irritability following Extreme Hydroxychloroquine Toxicity.

Authors:  Paul B McBeth; Perseus I Missirlis; Harry Brar; Vinay Dhingra
Journal:  Case Rep Emerg Med       Date:  2015-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.